Zaleplon
- PMID: 31855398
- Bookshelf ID: NBK551571
Zaleplon
Excerpt
Insomnia is a highly prevalent disorder in the US and worldwide. Insomnia is defined as the presence of long sleep latency, frequent nocturnal awakenings, or prolonged periods of wakefulness during the sleep period, or even frequent transient arousals. Zaleplon is a medication used in the management and treatment of insomnia. It is in the hypnotic class of drugs but is unrelated to benzodiazepines, barbiturates. This activity reviews the indications, actions, and contraindications for zaleplon when using it as a valuable agent in managing insomnia.
Copyright © 2025, StatPearls Publishing LLC.
Conflict of interest statement
Sections
References
-
- Sateia MJ, Doghramji K, Hauri PJ, Morin CM. Evaluation of chronic insomnia. An American Academy of Sleep Medicine review. Sleep. 2000 Mar 15;23(2):243-308. - PubMed
-
- Lichstein KL, Durrence HH, Taylor DJ, Bush AJ, Riedel BW. Quantitative criteria for insomnia. Behav Res Ther. 2003 Apr;41(4):427-45. - PubMed
-
- Ancoli-Israel S, Roth T. Characteristics of insomnia in the United States: results of the 1991 National Sleep Foundation Survey. I. Sleep. 1999 May 01;22 Suppl 2:S347-53. - PubMed
-
- Borbély AA, Achermann P. Ultradian dynamics of sleep after a single dose of benzodiazepine hypnotics. Eur J Pharmacol. 1991 Mar 19;195(1):11-8. - PubMed
Publication types
LinkOut - more resources
Full Text Sources